Detalles de la búsqueda
1.
Induction of MTHFD2 in Macrophages Inhibits Reactive Oxygen Species-mediated NF-κB Activation and Protects against Inflammatory Responses.
J Immunol
; 212(8): 1345-1356, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38407485
2.
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
BMC Med
; 22(1): 42, 2024 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281914
3.
Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
Eur Radiol
; 34(4): 2244-2255, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740779
4.
The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy.
Radiol Med
; 129(2): 188-201, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180570
5.
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.
BMC Cancer
; 23(1): 1009, 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858111
6.
Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance.
J Magn Reson Imaging
; 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942838
7.
Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression.
Dig Dis Sci
; 68(3): 841-851, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650416
8.
HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
J Cell Physiol
; 236(5): 3863-3880, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33305825
9.
A novel internal cold circulation radiofrequency-assisted device for liver transection.
Int J Hyperthermia
; 38(1): 308-315, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33627010
10.
miR-96 exerts carcinogenic effect by activating AKT/GSK-3ß/ß-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.
Cancer Cell Int
; 19: 38, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30828264
11.
S-15 in combination of Akt inhibitor promotes the expansion of CD45RA-CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1+Tim-3+ cells as well as regulatory T cells.
Cancer Cell Int
; 19: 322, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31827396
12.
Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
Eur Radiol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38285106
13.
The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations.
J Hepatol
; 77(2): 574-576, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35351522
14.
Tumor-infiltrating CD4+ T cells in patients with gastric cancer.
Cancer Cell Int
; 17: 114, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29213216
15.
Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.
Tumour Biol
; 37(11): 15265-15274, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27696294
16.
Laparoscopic liver resection versus radiofrequency ablation for caudate lobe solitary hepatocellular carcinoma: A propensity score matching study.
Cancer Med
; 13(4): e7068, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457235
17.
Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull's eye for targeted therapy?
Front Immunol
; 15: 1340726, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504984
18.
Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
Int J Surg
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626431
19.
[Loss of expression and mechanism of early growth response gene-3 in human oral squamous carcinoma].
Zhonghua Yi Xue Za Zhi
; 93(32): 2549-52, 2013 Aug 27.
Artículo
en Zh
| MEDLINE | ID: mdl-24351594
20.
[Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 21(10): 728-33, 2013 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-24331628